Integer Holdings Corporation Overview
Pro stress-test →Integer Holdings is a leading medical device contract development and manufacturing organization (CDMO) serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company generated $1.72 billion in revenue in 2024 with 10.35% growth and serves multinational original equipment manufacturers globally across multiple therapeutic areas.
Strategic Profile
Pro stress-test →Integer leverages its manufacturing and design capabilities to provide end-to-end solutions from component manufacturing to full device development. The company focuses on high-potential end markets with a proven track record of above-market organic growth and margin expansion through operational excellence and strategic acquisitions.
Competitive Landscape
Pro stress-test →Integer competes with other medical device CDMOs including Flex Electronics, Jaco Electronics, and Sanmina in the outsourced manufacturing space. Key differentiation stems from specialized capabilities in implantable devices, cardiac rhythm management, and neuromodulation, combined with established relationships with major medical device OEMs. The sector benefits from structural demand for outsourced manufacturing as large OEMs focus on innovation rather than manufacturing.
Industry Context
Integer Holdings Corporation operates in Medical Device Contract Manufacturing / CDMO.
Key facts
Founded: 1970 · Headquarters: Plano, Texas, United States · Revenue: $1.72B · Market cap: N/A